- Home
- MPX vs LUNG Comparison
MPX vs LUNG Comparison
Compare MPX & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPX
- LUNG
- Stock Information
- Founded
- MPX 1965
- LUNG 1995
- Country
- MPX United States
- LUNG United States
- Employees
- MPX N/A
- LUNG N/A
- Industry
- MPX Marine Transportation
- LUNG Industrial Specialties
- Sector
- MPX Industrials
- LUNG Health Care
- Exchange
- MPX Nasdaq
- LUNG Nasdaq
- Market Cap
- MPX 336.7M
- LUNG 290.8M
- IPO Year
- MPX N/A
- LUNG 2020
- Fundamental
- Price
- MPX $9.84
- LUNG $6.42
- Analyst Decision
- MPX Hold
- LUNG Strong Buy
- Analyst Count
- MPX 1
- LUNG 6
- Target Price
- MPX $8.00
- LUNG $13.83
- AVG Volume (30 Days)
- MPX 28.4K
- LUNG 227.0K
- Earning Date
- MPX 10-24-2024
- LUNG 10-30-2024
- Dividend Yield
- MPX 5.71%
- LUNG N/A
- EPS Growth
- MPX N/A
- LUNG N/A
- EPS
- MPX 0.53
- LUNG N/A
- Revenue
- MPX $259,608,000.00
- LUNG $79,302,000.00
- Revenue This Year
- MPX N/A
- LUNG $22.26
- Revenue Next Year
- MPX $5.00
- LUNG $18.72
- P/E Ratio
- MPX $18.50
- LUNG N/A
- Revenue Growth
- MPX N/A
- LUNG 22.34
- 52 Week Low
- MPX $8.86
- LUNG $5.46
- 52 Week High
- MPX $12.47
- LUNG $14.84
- Technical
- Relative Strength Index (RSI)
- MPX 54.72
- LUNG 45.42
- Support Level
- MPX $9.45
- LUNG $5.84
- Resistance Level
- MPX $10.04
- LUNG $7.67
- Average True Range (ATR)
- MPX 0.27
- LUNG 0.48
- MACD
- MPX -0.01
- LUNG -0.07
- Stochastic Oscillator
- MPX 49.46
- LUNG 29.29
About MPX Marine Products Corporation
Marine Products Corp is a manufacturer of fiberglass motorized boats distributed and marketed through its independent dealer network. The company's only operating segment is Powerboat Manufacturing Business. It operates in the Powerboat Manufacturing business segment through Nashville, Georgia, Valdosta, and Georgia. Its product offerings include Chaparral sterndrive, outboard pleasure boats and Robalo outboard sport fishing boats. The company offers its products to the family recreational markets through its Chaparral brand and to the sportfishing market through its Robalo brand.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.